DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for VBI Vaccines Inc. (VBIV)
« Back to company indexVBIV Chatter Timeline
Stock Ticker for VBIV
Most Active Tweeters for VBIV
| User | Tweets |
|---|---|
| @iamkevthegreat | 14 |
| @Bullish_Trades | 12 |
| @Gambiste1 | 9 |
| @Escells | 5 |
| @realestategabe1 | 4 |
Recent Tweets for VBIV
 |
@BiotechFun @BonanzaBiotech Best wishes and hope the best. $vbiv will triple its only a matter of time.. November 19th 2019, 5:11pm |
 |
@MarcoDaCostaFX RT @MrZackMorris: $VBIV $ADXS both offering good swing entries November 19th 2019, 4:11pm |
 |
@Kevin_W81 $VBIV Added a small chunk below $0.59 3-5 more weeks for ??? November 19th 2019, 4:11pm |
 |
@MrZackMorris $VBIV $ADXS both offering good swing entries November 19th 2019, 3:11pm |
 |
@marecare1971 $VBIV Friday news from phase 2 results! 1$ land November 19th 2019, 1:11pm |
 |
@MarkBagger $VBIV locked and loaded, waiting for the real run to start. Good Luck $VBIV https://t.co/H45ViCb3SQ November 19th 2019, 1:11pm |
 |
@realestategabe1 $VBIV shorts are in trouble ... going to get blazed ??? November 19th 2019, 12:11pm |
 |
@SwingTradeBot Rose Above Upper Bollinger Band today: $RYN $VBIV ... https://t.co/AyIukUGmib November 19th 2019, 12:11pm |
 |
@Bullish_Swag $VBIV Okay, you now have my attention ? November 19th 2019, 12:11pm |
 |
@StockInferno $VBIV interesting activity today, hmm.. news coming? Markets know before we do. November 19th 2019, 12:11pm |
 |
@Bullish_Trades $VBIV someone’s loading up heavy .61, constant large bids November 19th 2019, 10:11am |
|
@Bullish_Trades $VBIV .622 break for the next leg up November 19th 2019, 10:11am |
 |
@d_pavlos $VBIV Daily chart My penny stock https://t.co/7fPrafeYxc November 19th 2019, 10:11am |
|
@Bullish_Trades $VBIV on a roll today November 19th 2019, 9:11am |
 |
@ConsumerFeed VBI Vaccines $VBIV Receives New Coverage from Analysts at Raymond James https://t.co/yADs5Xa5hk November 18th 2019, 3:11pm |
|
@Bullish_Trades $VBIV waking up to $1+ soon. Most confident swing I’ve been holding for almost 2 months — paytience https://t.co/qQ1WGF7jFy November 18th 2019, 10:11am |
|
@Bullish_Trades $WTRH .30’s today $VBIV .60’s today November 18th 2019, 9:11am |
 |
@Gambiste1 RT @iamkevthegreat: Initial human proof-of-concept data from the Phase 1b/2a clinical study are expected in the second half of 2020. $VBIV November 18th 2019, 3:11am |
|
@Gambiste1 RT @iamkevthegreat: and enabling immune-mediated clearance of HBV-infected hepatocytes. $VBIV November 18th 2019, 3:11am |
 |
@iamkevthegreat Initial human proof-of-concept data from the Phase 1b/2a clinical study are expected in the second half of 2020. $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat The Phase 1b/2a clinical study of BRII-179 (VBI-2601) is a randomized, controlled study designed to assess the safety, tolerability, $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat and enabling immune-mediated clearance of HBV-infected hepatocytes. $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat and we look forward to sharing the initial human proof-of-concept results from this study in the second half of 2020.” $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat We believe BRII-179 (VBI-2601) has the potential to be a critical and differentiated component of a functional cure for HBV.” $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat VBI Vaccines and Brii Biosciences Initiate Phase 1b/2a Study of BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B Infection $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat is a subsequent extension phase with narrower enrollment criteria, designed to explore initial potential efficacy signals. $VBIV November 18th 2019, 2:11am |
|
@iamkevthegreat VBI Vaccines to Present Initial Phase 1/2a Part B Data of VBI-1901 at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting $VBIV November 18th 2019, 2:11am |
 |
@ZolmaxNews VBI Vaccines $VBIV Receives New Coverage from Analysts at Raymond James https://t.co/YVG31cYp5s November 18th 2019, 12:11am |
 |
@dailypoliticaln VBI Vaccines $VBIV Earns Outperform Rating from Analysts at Raymond James https://t.co/m23ArVKOfI November 18th 2019, 12:11am |
 |
@Rob54549026 RT @Bromus93: $VBIV Reasons why I see value in this: 1. Presenting phase 1/2 data at SNO meeting on November 22 2. Closed above the 8/20/5… November 17th 2019, 6:11pm |
 |
@Bromus93 $VBIV Reasons why I see value in this: 1. Presenting phase 1/2 data at SNO meeting on November 22 2. Closed above… https://t.co/K7eDNWJewW November 17th 2019, 2:11pm |
 |
@TopStockAlerts1 $VBIV should continue to gap up to $1 November 17th 2019, 11:11am |
|
@Bullish_Trades $VBIV great close, .60’s next week November 15th 2019, 4:11pm |
|
@Gambiste1 RT @moshakes_911: $Eros, $VBIV Great close November 15th 2019, 4:11pm |
|
@Gambiste1 RT @Idahojoe82: $VBIV in for a swing up to data NOV 22nd with the additional upgrade of PT$3, looking for .80-1.20 November 15th 2019, 4:11pm |
|
@Gambiste1 RT @realestategabe1: $VBIV the gift that keeps on giving ?? November 15th 2019, 4:11pm |
|
@Gambiste1 RT @BonanzaBiotech: Moving slowly and nicely now $VBIV November 15th 2019, 4:11pm |
 |
@moshakes_911 $Eros, $VBIV Great close November 15th 2019, 4:11pm |
 |
@BonanzaBiotech Moving slowly and nicely now $VBIV November 15th 2019, 1:11pm |
 |
@Idahojoe82 $VBIV in for a swing up to data NOV 22nd with the additional upgrade of PT$3, looking for .80-1.20 November 15th 2019, 1:11pm |
|
@realestategabe1 $VBIV the gift that keeps on giving ?? November 15th 2019, 1:11pm |
|
@BonanzaBiotech Tight at the 50 day....will pop soon enough. $VBIV https://t.co/XAlPzS534Z November 15th 2019, 10:11am |
|
@BonanzaBiotech Have to be patient here. This will get going in the days ahead. $VBIV November 15th 2019, 10:11am |
|
@dailypoliticaln Analysts Set Expectations for VBI Vaccines Inc’s FY2019 Earnings $VBIV https://t.co/NucbfsZQCo November 15th 2019, 1:11am |
|
@ZolmaxNews Analysts Set Expectations for VBI Vaccines Inc’s FY2019 Earnings $VBIV https://t.co/RbtFZX02gT November 15th 2019, 1:11am |
|
@Gambiste1 RT @BakkenShale: $VBIV VBI Vaccines Initiated at Outperform by Raymond James November 14th 2019, 11:11pm |
 |
@TargetPrices $VBIV Initiates Coverage OnRaymond JamesOutperform3 https://t.co/Ex3F3bBnvP November 14th 2019, 8:11pm |
|
@moshakes_911 RT @Kevin_W81: $VBIV Secretly bought more @ $0.56 Nice PR this morning, Partnered with Brii Biosciences and launched a new trial. All exp… November 14th 2019, 6:11pm |
 |
@BakkenShale $VBIV VBI Vaccines Initiated at Outperform by Raymond James November 14th 2019, 6:11pm |
 |
@Varro_Analytics @MSollender 44). Perceptive Advisors buys Motley mix $VBIV +20.0M sh (11.2% of co) – vaccine, data coming $FOMX +… https://t.co/jxQ41Fxvfq November 14th 2019, 6:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.